Olivier Brandicourt

Sanofi Pasteur HQ

Biotech

GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out

Sanofi says its GLP-1 drug SAR425899 is undertaking new tests to try to get around dosing issues that is causing GI problems.

Ben Adams Apr 27, 2018 10:02am

Parachute

Chutes & Ladders—Allergan lures new CFO from Catalent

Feb 9, 2018 3:22am

Parachute landscape

Chutes & Ladders—Sanofi Genzyme’s chief bows out

Apr 6, 2017 3:42pm